Corpus Intelligence IC Memo — SCOTLAND MEMORIAL HOSPITAL 2026-04-26 06:56 UTC
IC Memo — SCOTLAND MEMORIAL HOSPITAL
Investment Committee Memorandum | NC | 104 beds | Grade B | EBITDA uplift $14.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SCOTLAND MEMORIAL HOSPITAL

CCN 340008 | SCOTLAND, NC | 104 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

SCOTLAND MEMORIAL HOSPITAL is a 104-bed suburban community hospital in SCOTLAND, NC with $198.0M in net patient revenue and a -2.8% operating margin. The hospital serves a payer mix of 21.6% Medicare, 9.0% Medicaid, and 69.4% commercial.

Thesis: Undervalued. Our ML models identify $14.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -2.8% to 4.6% (+736bps).

Net Revenue HCRIS$198.0M
Current EBITDA COMPUTED$-5.6M
Operating Margin COMPUTED-2.8%
Occupancy HCRIS74.1%
Revenue / Bed COMPUTED$1.9M
Net-to-Gross HCRIS27.7%
Distress Probability ML42.3%

2. Market Context & Competitive Position

129
NC Hospitals
-2.0%
State Median Margin
57
Comparable Hospitals

NC has 129 Medicare-certified hospitals with a median operating margin of -2.0%. The target's margin of -2.8% places it below the state median. Among 57 size-comparable peers (52-208 beds), the median margin is -1.4%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (52-208), prioritizing same-state peers. 57 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SCOTLAND MEMORIAL HOSPITAL (Target)NC104$198.0M-2.8%
DUKE RALEIGH HOSPITALNC186$683.0M3.7%
CATAWBA VALLEY MEDICAL CENTERNC200$451.9M5.9%
MARGARET R. PARDEE MEMORIAL HONC160$341.3M-5.7%
JOHNSTON HEALTHNC179$331.7M9.6%
WAKE MED CARY HOSPITALNC189$318.1M-3.6%
ATRIUM HEALTH UNIONNC183$302.3M7.0%
S.E. REGL MEDICAL CENTERNC179$298.1M-25.3%
ATRIUM HEALTH UNIVERSITY CITYNC104$286.9M28.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $14.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$4.2M+210bp18mo
Cost to Collect4.5%2.5%$4.0M+200bp12mo
Denial Rate Reduction12.0%6.5%$3.9M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.4M+122bp9mo
Clean Claim Rate88.0%96.0%$127K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$4.2M
Cost to Collect
$4.0M
Denial Rate Reduction
$3.9M
A/R Days Reduction
$2.4M
Clean Claim Rate
$127K
Total EBITDA Uplift$14.6M
Current EBITDA$-5.6M
+ RCM Uplift+$14.6M
Pro Forma EBITDA$9.0M
Current Margin-2.8%
Pro Forma Margin4.6%
WC Released (1x)$7.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-8.6M$109.0M0.00x-100.0%
Base (11x exit)10.0x11.0x$-8.6M$117.2M0.00x-100.0%
Bull Case9.0x11.0x$-7.7M$162.5M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-7.7M$175.0M0.00x-100.0%
Bear Case11.0x10.0x$-9.4M$38.9M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-9.4M$39.8M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 57 hospitals with 52-208 beds
  • Same-state prioritization (n=58)
  • Comp margins: P25=-8.8% / P50=-1.4% / P75=6.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.